Chi-Med IPO covered as Manulife US Reit shuffles banks
Hutchison China MediTech’s (Chi-Med) $100m IPO on the Nasdaq has been oversubscribed three days into bookbuilding, according to sources close to the transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: